|
Volumn 72, Issue 6, 2001, Pages 1050-1055
|
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression
a,b a,b a,c a,c a,d a,d a,e a,e a,f a,f a,g a,g a,h a,h a,i a,i a,j a,k a,k a,l more..
d
HÔPITAL NORD
(France)
e
CHU RANGUEIL
(France)
i
CHU BRETONNEAU
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
AZATHIOPRINE;
CORTICOSTEROID;
GANCICLOVIR;
OKT 3;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
ANEMIA;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GRAFT SURVIVAL;
HERPES;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FAILURE;
KIDNEY GRAFT REJECTION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SERUM SICKNESS;
SURVIVAL RATE;
THROMBOCYTOPENIA;
|
EID: 0035960019
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/00007890-200109270-00012 Document Type: Article |
Times cited : (171)
|
References (20)
|